focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.50
Ask: 4.50
Change: 0.49 (13.96%)
Spread: 1.00 (28.571%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings

Thu, 30th Nov 2023 11:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Ashtead Technology Holdings PLC, up 20% at 582.00 pence, 12-month range 281.00p-594.00p. The subsea equipment rental, serving the offshore energy sector, says it now expects 2023 results to be "comfortably ahead of its previous expectations". It also announces a GBP53.5 million deal to acquire ACE Winches, from that firm's founders Alfie and Valerie Cheyne. ACE offers lifting, pulling and deployment services, and will sit nicely with "Ashtead Technology's existing equipment and services portfolio", it says.

----------

AIM - LOSERS

----------

Proteome Sciences PLC, down 25% at 4.54p, 12-month range 3.15p-8.79p. The protein-focused drug development services provider cuts its revenue outlook for 2023 amid delays to projects. It expects its top line to shrink from 2022's GBP7.8 million. "As reported by many other life science technology providers, the company has experienced delays to projects, many of which have been postponed to 2024. The healthcare industry has faced a very challenging market environment this year, especially in the second half of the year," Proteome Sciences explains. Proteome adds that reduced revenue combined with its commitment to invest in a US lab, means its now expects to post a net loss for 2023. In 2022, the company posted a profit after tax of GBP1.3 million. Proteome says it expects its US laboratory to be operational in the coming weeks and is lining up first customer projects for this laboratory.

----------

Totally PLC, down 16% at 4.85p, 12-month range 4.80p-38.00p. A poor week for the stock continues and it looks likely to suffer a fourth-successive share price decline. On Tuesday, the healthcare services provider in UK and Ireland reported that it swung to a pretax loss of GBP1.9 million in the first half ended September 30, from a profit of GBP1.0 million the year prior. Revenue fell 21% to GBP55.8 million during the period, from GBP70.3 million a year ago, Totally said. The firm blamed a "crisis" faced by the UK NHS for the lower revenue, given the loss of its North West London contracts. Shares have fallen 48% so far this week and it hit this 12-month low on Thursday.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
29 Jul 2021 18:17

TRADING UPDATES: Headlam boosts outlook; Mothercare loss widens

TRADING UPDATES: Headlam boosts outlook; Mothercare loss widens

Read more
18 Jun 2021 19:20

IN BRIEF: Proteome Sciences amends loan facility with Vulpes

IN BRIEF: Proteome Sciences amends loan facility with Vulpes

Read more
19 May 2021 19:33

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
19 Apr 2021 20:40

IN BRIEF: Proteome Sciences Non-Executive Roger McDowell raises stake

IN BRIEF: Proteome Sciences Non-Executive Roger McDowell raises stake

Read more
1 Apr 2021 12:00

TRADING UPDATES: 4D Pharma loss widens on rise in administrative costs

TRADING UPDATES: 4D Pharma loss widens on rise in administrative costs

Read more
1 Apr 2021 10:34

AIM WINNERS & LOSERS: Oilex hails milestone with Cambay resolution

AIM WINNERS & LOSERS: Oilex hails milestone with Cambay resolution

Read more
31 Mar 2021 06:58

IN BRIEF: Proteome Sciences amends loan, gets extra year to pay back

IN BRIEF: Proteome Sciences amends loan, gets extra year to pay back

Read more
26 Mar 2021 13:02

Proteome profit to be higher than expected thanks to royalties boost

Proteome profit to be higher than expected thanks to royalties boost

Read more
26 Mar 2021 11:33

AIM WINNERS & LOSERS: Rotala skids on Burnham's Manchester bus reform

AIM WINNERS & LOSERS: Rotala skids on Burnham's Manchester bus reform

Read more
26 Mar 2021 08:37

Proteome expects FY profits to be 'materially higher' than previous guidance

(Sharecast News) - Protein biomarker research and development firm Proteome Sciences said on Friday that it has been progressing with a year-end audit and now expects to announce its 2020 full-year results on 1 April.

Read more
25 Jan 2021 16:17

TRADING UPDATES: IG Design Gets CSS Boost; FireAngel In Virus Hit

TRADING UPDATES: IG Design Gets CSS Boost; FireAngel In Virus Hit

Read more
14 Sep 2020 10:35

Proteome Shares Rise On Appointment Of Pharma Veteran Sohngen As CEO

Proteome Shares Rise On Appointment Of Pharma Veteran Sohngen As CEO

Read more
14 Sep 2020 08:39

Proteome Sciences announces new chief executive officer

(Sharecast News) - Proteome Sciences announced on Monday that Dr Mariola Söhngen has been appointed as a director and its chief executive officer, taking up the position on 15 September.

Read more
10 Aug 2020 10:15

Proteome First-Half Loss Widens As Cost Rise Trumps Revenue Climb

Proteome First-Half Loss Widens As Cost Rise Trumps Revenue Climb

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.